Prosecution Insights
Last updated: October 27, 2026

Leon B Lankford Jr., USPTO Patent Examiner

Listed by the USPTO as LANKFORD JR, LEON B

Tech Center 1700 • Art Units: 1651 1657 1677 1692 1798

This examiner grants 70% of resolved cases

Analysis

LANKFORD JR, LEON B is assigned to Tech Center 1700 and art unit 1651. The profile reports 756 resolved cases, an allowance rate of 70.0%, and a median of 1352 days to allowance. Interviews are associated with a 31.5% lift in the allowance rate. The timing and interview measures together support advance planning for response cycles and direct discussions with the examiner.

The listed companies are Roche Diagnostics Operations Inc., Hoffmann-La Roche Inc., and Janssen Pharmaceuticals Inc. The listed firms are Taft Law, BIRCH STEWART KOLASCH & BIRCH, LLP, and Adams & Reese LH. These appearances give practitioners a way to identify counsel and applicants with experience in the docket. The profile is useful for strategy development, but its aggregate figures should not be read as a guarantee of allowance for a specific application.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

70.0%
Allow Rate
+5.0% vs TC avg
783
Total Applications
+31.5%
Interview Lift
1352
Avg Prosecution Days
Based on 756 resolved cases, 2023–2026

Rejection Statute Breakdown

6.6%
§101 Eligibility
14.4%
§102 Novelty
42.5%
§103 Obviousness
27.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18526020 IDENTIFICATION AND QUANTITATION OF RESIDUAL HOST CELL PROTEINS IN PROTEIN SAMPLES Final Rejection HOFFMANN-LA ROCHE INC.
18863011 BACTERIAL MYELOPEROXIDASE-CATALASE AND APPLICATIONS THEREOF Non-Final OA CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
18284108 METHODS FOR PREPARING L-GLUFOSINATE Non-Final OA BASF SE
18037646 TISSUE ORGANOID BIOPRINTING AND HIGH-THROUGHPUT SCREENING METHODOLOGY Non-Final OA The Regents of the University of California
18294648 NOVEL FLAVIN-DEPENDENT LACTATE DEHYDROGENASE AND METHOD FOR IMPROVING STABILITY OF LACTATE DEHYDROGENASE Non-Final OA KIKKOMAN CORPORATION
18892143 SYSTEMS AND METHODS FOR OPTIMIZED PATIENT SPECIFIC TISSUE ENGINEERING VASCULAR GRAFTS Non-Final OA Research Institute at Nationwide Children's Hospital
17865875 ANTI-FIBROSIS AGENT AND METHOD OF PRODUCING EXTRACELLULAR VESICLE HAVING ANTI-FIBROSIS ACTION Final Rejection FUJIFILM Wako Pure Chemical Corporation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Leon B Lankford Jr.'s allowance rate?

70.0% of resolved applications examined by Leon B Lankford Jr. were allowed (756 resolved cases), compared with 31.6% across Art Unit 1651 over the last five years.

Does an interview help with examiner Leon B Lankford Jr.?

This examiner's interview lift is +31.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Leon B Lankford Jr. take to allow a patent?

Applications allowed by Leon B Lankford Jr. took 1,352 days on average from filing to allowance.

Which art unit does examiner Leon B Lankford Jr. work in?

Leon B Lankford Jr. examines applications in Art Unit 1651 in Tech Center 1700 (Chemistry & Materials).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month